We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
After receiving permission to make Bharat Biotech’s COVID-19 vaccine Covaxin, Haffkine Bio-Pharmaceutical said it would take least at one year’s time for the company to start actual production.